<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01918163</url>
  </required_header>
  <id_info>
    <org_study_id>0059-13HYMC</org_study_id>
    <nct_id>NCT01918163</nct_id>
  </id_info>
  <brief_title>Anti-oxidative Influence From Pomegranate Tablets on Male Sperm Quality in Couples Undergo Infertility Treatments Due to Male Infertility.</brief_title>
  <acronym>Pomegranate</acronym>
  <official_title>Anti-oxidative Influence From Pomegranate Tablets on Male Sperm Quality in Couples Undergo Infertility Treatments Due to Male Infertility.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hillel Yaffe Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hillel Yaffe Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Some animal studies revealed that the pomegranate juice may improve sperm quality in terms of
      concentration, motility and morphology, as well as in fertilization rate.

      Minor data is available regarding the influence on male sperm.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pomegranate contains a high concentration of vitamins ( C, B1, B2, B3, B5), potassium,
      Magnesium , Zinc and is a good source for polyphenols .Polyphenols molecules have been found
      to possess antioxidant properties and may effects the expression of different genes . Recent
      studies indicate that among foods that contain polyphenols, juice extracted from the
      pomegranate has the highest concentration of measurable polyphenols . Pomegranates have shown
      inhibitory effect on NF-κB and the MAP kinases JNK and ERK, which are critical steps in the
      cascade of events leading to inflammatory response. The NF- κB pathway is activated in
      response to bacterial infection and initiates the inflammatory cascade, which may explain the
      protective effect of Pomegranates on bacterial infections.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>September 2013</start_date>
  <completion_date type="Anticipated">September 2014</completion_date>
  <primary_completion_date type="Anticipated">September 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>pregnancy</measure>
    <time_frame>24 month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>ROS (reactive oxidative stress )and Interleukins level in semen fluid</measure>
    <time_frame>12 weeks</time_frame>
    <description>The unit for measure the ROS are Micromolar epicatechin equivalent</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">55</enrollment>
  <condition>Male Infertility With Severe Oligo-terato-asteno-spermia</condition>
  <arm_group>
    <arm_group_label>No Pills</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients in this group will not receive Pomegranate pills.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pomegranate pills</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The reccruited patient will receive pomegranate pills every day for 12 weeks. The control group will not be exposed for the pills.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Pomegranate pills</intervention_name>
    <arm_group_label>Pomegranate pills</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  TMC of less than 5 million spermatogonia in native sperm and morphology less than 4%
             by Kruger criteria.

        Exclusion Criteria:

          -  sensitivity to Pomegranate
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Einat Shalom-Paz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hillel Yaffe Medical center, IVF unit, Hadera, Israel</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Einat Shalom-Paz, MD</last_name>
    <phone>972544899155</phone>
    <email>einatshalompaz@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ellenbogen Adrian, MD</last_name>
    <phone>973506246722</phone>
    <email>ellenbogen@hy.health.gov.il</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hillel Yaffe Medical Center</name>
      <address>
        <city>Hadera</city>
        <zip>38100</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Reuma Barkan</last_name>
      <phone>97246304223</phone>
      <email>reuma@hy.health.gov.il</email>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 14, 2013</study_first_submitted>
  <study_first_submitted_qc>August 6, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 7, 2013</study_first_posted>
  <last_update_submitted>August 6, 2013</last_update_submitted>
  <last_update_submitted_qc>August 6, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 7, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>pomegranate pills, male infertility, pregnancy rate, semen analysis, ROS, oxidative stress</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
    <mesh_term>Infertility, Male</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

